CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation
Molecular Cell · 2026
DOI: 10.1016/j.molcel.2026.08.029 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Cell, 2026. Verfasst von Carolyn Nicole Brown und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Hauptthemen laut MEDLINE: Calcium-Calmodulin-Dependent Protein Kinase Type 2, Receptors, N-Methyl-D-Aspartate, Long-Term Potentiation, Synapses. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMH NIH HHS, NINDS NIH HHS, NIDA NIH HHS.
Abstract (Originalsprache)
Cognitive functions require synaptic plasticity, specifically long-term potentiation (LTP). LTP is thought to require Ca2+/CaM-dependent protein kinase II (CaMKII) binding to the NMDA-type glutamate receptor subunit GluN2B, but this poses a conundrum: truncated CaMKII monomers (without the hub domain that forms 12meric holoenzymes) fail to bind GluN2B within cells but still potentiate synapses when made constitutively active. We hypothesized that CaMKII monomer binding to GluN2B has just eluded detection. Instead, even though full-length CaMKII monomers (with hub-domain mutations) were found to indeed bind and even form condensates with GluN2B, truncated monomers were not. Nonetheless, truncated monomers still potentiated synapses, even in neurons with GluN2B mutations that ablate CaMKII binding. However, potentiation occurred only with monomers that were made Ca2+-independent by artificial phosphatase-resistant thio-autophosphorylation, not by regular autophosphorylation of T286. These findings support that CaMKII binding to GluN2B is required during physiological LTP induction because it generates the phosphatase-resistant autonomous activity that mediates LTP expression.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
- Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA. Electronic address: ulli.bayer@cuanschutz.edu.
Förderung
- NIMH NIH HHS
- NINDS NIH HHS
- NIDA NIH HHS
- NIGMS NIH HHS
- NIA NIH HHS
- NIDDK NIH HHS
- National Institute on Drug Abuse
- National Institute of Mental Health and Neurosciences
Zitieren
APA
Brown, C. N., Barker, C. M., Miller, C. N., Chao, F. Y., Aoto, J., Coultrap, S. J., & Bayer, K. U. (2026). CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation. Molecular Cell. https://doi.org/10.1016/j.molcel.2026.08.029
Vancouver
Brown CN, Barker CM, Miller CN, Chao FY, Aoto J, Coultrap SJ, et al. CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation. Molecular Cell. 2026. doi:10.1016/j.molcel.2026.08.029
BibTeX
@article{Brown2026,
author = {Brown, Carolyn Nicole and Barker, C Madison and Miller, Carley N and Chao, Fan-Yi and Aoto, Jason and Coultrap, Steven J and Bayer, K Ulrich},
title = {CaMKII monomers are sufficient for GluN2B binding, co-condensation, and synaptic potentiation},
journal = {Molecular Cell},
year = {2026},
doi = {10.1016/j.molcel.2026.08.029}
}
EUVIMED